Experientia supplementum (2012) : Impact Factor & More
pISSN: 1664-431X
Share this on:
Key Metrics
CiteScore 
2
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Experientia supplementum (2012) Journal Specifications
Indexed in the following public directories
Scopus
| Overview | |
| Publisher | Springer Nature |
Planning to publish in Experientia supplementum (2012) ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Experientia supplementum (2012)
Role of ncRNAs in Neurological Disorders and Cardiovascular Diseases.
- 1 Jan 2026
- Experientia supplementum (2012)
Exploring the Role of Long Noncoding RNAs (lncRNAs) as Biomarkers in Cancers.
- 1 Jan 2026
- Experientia supplementum (2012)
The Transcriptional Role of Circular RNAs in Drug Resistance by Modulating the miRNA/mRNA Axis.
- 1 Jan 2026
- Experientia supplementum (2012)
Noncoding RNA in Clinical Trials: Diagnostic and Therapeutical Prospects.
- 1 Jan 2026
- Experientia supplementum (2012)
MicroRNAs as Biomarkers for the Diagnosis and Prognosis of Different Diseases and Cancer.
- 1 Jan 2026
- Experientia supplementum (2012)
MitomiRs as Key Players in Metabolic Reprogramming of Blood Cell Development.
- 1 Jan 2026
- Experientia supplementum (2012)
Role of ncRNAs in Neurological Disorders and Cardiovascular Diseases.
- 1 Jan 2026
- Experientia supplementum (2012)
Exploring the Role of Long Noncoding RNAs (lncRNAs) as Biomarkers in Cancers.
- 1 Jan 2026
- Experientia supplementum (2012)
The Transcriptional Role of Circular RNAs in Drug Resistance by Modulating the miRNA/mRNA Axis.
- 1 Jan 2026
- Experientia supplementum (2012)
Noncoding RNA in Clinical Trials: Diagnostic and Therapeutical Prospects.
- 1 Jan 2026
- Experientia supplementum (2012)
MicroRNAs as Biomarkers for the Diagnosis and Prognosis of Different Diseases and Cancer.
- 1 Jan 2026
- Experientia supplementum (2012)
MitomiRs as Key Players in Metabolic Reprogramming of Blood Cell Development.
- 1 Jan 2026
- Experientia supplementum (2012)
FAQs on Experientia supplementum (2012)
How many articles did Experientia supplementum (2012) publish last year? 
What is Citescore for Experientia supplementum (2012)?
Who is the publisher of Experientia supplementum (2012)?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2022 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations